Emerging antimicrobial resistance in Neisseria gonorrhoeae:: Urgent need to strengthen prevention strategies

被引:127
作者
Workowski, Kimberly A.
Berman, Stuart M.
Douglas, John M.
机构
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Ctr Dis Control & Prevent, Nat Ctr HIV AIDS, Atlanta, GA USA
关键词
D O I
10.7326/0003-4819-148-8-200804150-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevention and control of gonorrhea is an important public health concern due to the high burden of disease, the recent increase in reported infection rates, and the reproductive and economic consequences of infection. Effective antibiotic treatment is one essential component of an integrated approach to gonorrhea control. Over the past 60 years, however, development of resistance in Neisseria gonorrhoeae to multiple antimicrobial classes challenges this component of gonorrhea control. An integrated, comprehensive prevention strategy should include enhancement of national and international surveillance systems to monitor antimicrobial resistance and new strategies to maximize the benefit and prolong the utility of antimicrobials, including combination regimens, implementation of screening recommendations for individuals at high risk for infection, and the assurance of prompt and effective treatment for infected persons and their sexual partners. Progress in controlling the epidemic and avoiding a resurgence as treatment options wane will require careful attention to all components of a comprehensive prevention strategy.
引用
收藏
页码:606 / 613
页数:8
相关论文
共 59 条
  • [21] del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332
  • [22] Testing for sexually transmitted diseases in US Public Health Laboratories in 2004
    Dicker, Linda Webster
    Mosure, Debra J.
    Steece, Richard
    Stone, Katherine M.
    [J]. SEXUALLY TRANSMITTED DISEASES, 2007, 34 (01) : 41 - 46
  • [23] Eng T.R., 1997, The Hidden Epidemic: Confronting Sexually Transmitted Diseases
  • [24] From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection
    Fleming, DT
    Wasserheit, JN
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 1999, 75 (01) : 3 - 17
  • [25] Surveillance for repeat Gonorrhea infection, San diego, california, 1995-2001 - Establishing definitions and methods
    Gunn, RA
    Maroufi, A
    Fox, KK
    Berman, SM
    [J]. SEXUALLY TRANSMITTED DISEASES, 2004, 31 (06) : 373 - 379
  • [26] HALL C, 2007, 17 INT SOC STD RES S
  • [27] EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF UNCOMPLICATED GONORRHEA IN ADULTS AND ADOLESCENTS
    HANDSFIELD, HH
    MCCUTCHAN, JA
    COREY, L
    RONALD, AR
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 : S123 - S130
  • [28] Which cephalosporin for gonorrhoea?
    Ison, CA
    Mouton, JW
    Jones, K
    Fenton, KA
    Livermore, DM
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2004, 80 (05) : 386 - 388
  • [29] Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones
    Ito, M
    Yasuda, M
    Yokoi, S
    Ito, SI
    Takahashi, Y
    Ishihara, S
    Maeda, SI
    Deguchi, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 3185 - 3187
  • [30] Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000 - Role of foreign importation and increasing endemic spread
    Iverson, CJ
    Wang, SA
    Lee, MV
    Ohye, RG
    Trees, DL
    Knapp, JS
    Effler, PV
    O'Connor, NP
    Levine, WC
    [J]. SEXUALLY TRANSMITTED DISEASES, 2004, 31 (12) : 702 - 708